1-2 of 2
Bruno Benedetto
Close
Sort by
Journal Articles

Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation in Relapsed Hodgkin’s Lymphoma in Recent Years. a Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Sonja G Genadieva Stavrik, MDPhD, Ariane Boumendil, Kirsty Thomson, Javier Briones, MD, Paolo Corradini, MD, Andrea Bacigalupo, MD, Gerard Socie, Guiseppe Bandini, Herve Finel, Andrea Velardi, MD, Michael Potter, PhD, Bruno Benedetto, Luca Castagna, MD, Charles Craddock, MDPhD, Nigel Russell, Peter Dreger, MD, Sureda Anna
Journal: Blood
Blood (2014) 124 (21): 2562.
https://doi.org/10.1182/blood.V124.21.2562.2562
Published: 2014
Journal Articles

Long-Term Outcome of Autologous Followed by Nonmyeloablative Allografting from HLA-Identical Sibling for Multiple Myeloma (MM).

Marcello Rotta, MD, Barry Storer, PhD, Firoozeh Sahebi, MD, Judith A. Shizuru, MD PhD, Bruno Benedetto, MD PhD, Thoralf Lange, MD, Peter A. McSweeney, MD, Michael A. Pulsipher, MD, Parameswaran Hari, MD, Richard T. Maziarz, MD, Edward D. Agura, MD, Thomas Chauncey, MD, Frederick R. Appelbaum, MD, Mohamed L. Sorror, MD, William Bensinger, MD, Brenda M. Sandmaier, MD PhD, Rainer F. Storb, MD, David G. Maloney, MD PhD
Journal: Blood
Blood (2007) 110 (11): 3029.
https://doi.org/10.1182/blood.V110.11.3029.3029
Published: 2007